Cargando…
Photoactivation of MDM2 Inhibitors: Controlling Protein–Protein Interaction with Light
[Image: see text] Selectivity remains a major challenge in anticancer therapy, which potentially can be overcome by local activation of a cytotoxic drug. Such triggered activation can be obtained through modification of a drug with a photoremovable protecting group (PPG), and subsequent irradiation...
Autores principales: | Hansen, Mickel J., Feringa, Femke M., Kobauri, Piermichele, Szymanski, Wiktor, Medema, René H., Feringa, Ben L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194649/ https://www.ncbi.nlm.nih.gov/pubmed/30284823 http://dx.doi.org/10.1021/jacs.8b04870 |
Ejemplares similares
-
Mechanism of Resistance Development in E. coli against TCAT, a Trimethoprim-Based Photoswitchable Antibiotic
por: Lauxen, Anna I., et al.
Publicado: (2021) -
Photocontrol
of Antibacterial Activity: Shifting from
UV to Red Light Activation
por: Wegener, Michael, et al.
Publicado: (2017) -
Rational design of a photoswitchable DNA glue enabling high regulatory function and supramolecular chirality transfer
por: Simeth, Nadja A., et al.
Publicado: (2021) -
Hypothesis-Driven,
Structure-Based Design in Photopharmacology:
The Case of eDHFR Inhibitors
por: Kobauri, Piermichele, et al.
Publicado: (2022) -
General Principles for the Design of Visible‐Light‐Responsive Photoswitches: Tetra‐ortho‐Chloro‐Azobenzenes
por: Lameijer, Lucien N., et al.
Publicado: (2020)